Clinical Trial Update: MTX and Steroid as First-line Therapy for aGVHD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating methotrexate plus steroids as first-line therapy for acute graft-versus-host disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Corticosteroids (corticosteroids)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Acute GVH Disease | Phase 3 | Status: COMPLETED